SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Ranbaxy Laboratories launches Letrozole Tablets 2.5mg in UK, Romania and France

25 Jul 2011 Evaluate

Ranbaxy Laboratories has launched Letrozole Tablets 2.5mg in UK, Romania and France. Letrozole is the bio equivalent of Femera, the innovator product of Novartis, that has the market size of $58 million in UK, $9 million in France and $5.5 million in Romania. Letrozole is an Antineoplastics , indicated for the treatment of breast cancer.

Ranbaxy’s subsidiary companies, Ranbaxy (UK), Terapia Ranbaxy and Ranbaxy Pharmacy Generiques will be marketing this product in UK, Romania and France.

Ranbaxy Laboratories, is India's largest pharmaceutical company. The company has world-class manufacturing facilities in 11 countries namely Brazil, China, Ireland, India, Japan, Malaysia, Nigeria, Romania, South Africa, USA and Vietnam.

Peers
Company Name CMP
Sun Pharma Inds. 1837.15
Dr. Reddys Lab 1271.55
Cipla 1353.85
Zydus Lifesciences 1070.90
Lupin 2351.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: